Toxoplasmosis-associated neovascular lesions treated successfully with ranibizumab and antiparasitic therapy

Arch Ophthalmol. 2008 Aug;126(8):1152-6. doi: 10.1001/archopht.126.8.1152.
No abstract available

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antiprotozoal Agents / therapeutic use*
  • Child
  • Choroidal Neovascularization / diagnosis
  • Choroidal Neovascularization / drug therapy*
  • Choroidal Neovascularization / parasitology
  • Drug Therapy, Combination
  • Fluorescein Angiography
  • Humans
  • Injections
  • Leucovorin / therapeutic use
  • Male
  • Pyrimethamine / therapeutic use
  • Ranibizumab
  • Retinal Hemorrhage / diagnosis
  • Retinal Hemorrhage / drug therapy*
  • Retinal Hemorrhage / parasitology
  • Sulfadiazine / therapeutic use
  • Tomography, Optical Coherence
  • Toxoplasmosis, Ocular / diagnosis
  • Toxoplasmosis, Ocular / drug therapy*
  • Toxoplasmosis, Ocular / parasitology
  • Visual Acuity
  • Vitreous Body

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antiprotozoal Agents
  • Sulfadiazine
  • Leucovorin
  • Pyrimethamine
  • Ranibizumab